Interaction between gut microbiota and immune checkpoint inhibitor-related colitis

Interaction between gut microbiota and immune checkpoint inhibitor-related colitis

Immune checkpoint inhibitors (ICIs) have become a promising therapeutic strategy for malignant tumors, improving patient prognosis, along with a spectrum of immune-related adverse events (irAEs), including gastrointestinal toxicity, ICI-related colitis (IRC), and diarrhea. The gut microbiota has bee...

Full description

Bibliographic Details
Main Authors: Guanzhou Zhou, Nana Zhang, Ke Meng, Fei Pan
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-10-01
Series:Frontiers in Immunology
Subjects:
immune checkpoint inhibitor
gut microbiota
colitis
diarrhea
microbiome
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.1001623/full

Similar Items

Similar Items